These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6169955)

  • 41. Hypertension--drug management.
    Anand MP
    J Assoc Physicians India; 1982 Feb; 30(2):101-5. PubMed ID: 6132908
    [No Abstract]   [Full Text] [Related]  

  • 42. Rationale for combined alpha-beta-adrenoceptor blockade: haemodynamic considerations.
    Koch G
    Acta Med Scand Suppl; 1982; 665():87-92. PubMed ID: 6130680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
    Lund-Johansen P
    Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Labetalol in the treatment of angina pectoris.
    Kanto JH
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):166-74. PubMed ID: 2881899
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of hypertension with the alpha- and beta-adrenergic blockader trandat].
    Erina EV; Charyev KhE; Lediashova GA; Smolenskiĭ AV
    Ter Arkh; 1983; 55(9):43-8. PubMed ID: 6314576
    [No Abstract]   [Full Text] [Related]  

  • 46. An overview of the pharmacodynamic properties and therapeutic potential of combined alpha- and beta-adrenoceptor antagonists.
    van Zwieten PA
    Drugs; 1993 Apr; 45(4):509-17. PubMed ID: 7684671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Use of the alpha- and beta-adrenergic blocker labetalol in hypertensive crises].
    Kharchenko VI; Savenkov PM; Romanova LV; Arkhipov SN; Borisova GG
    Sov Med; 1983; (9):84-8. PubMed ID: 6648691
    [No Abstract]   [Full Text] [Related]  

  • 48. Labetalol in hypertension.
    Lancet; 1977 Apr; 1(8017):890-1. PubMed ID: 67294
    [No Abstract]   [Full Text] [Related]  

  • 49. Raynaud's phenomenon caused by beta-receptor blocking drugs. Improvement after treatment with a combined alpha- and beta-blocker.
    Eliasson K; Danielson M; Hylander B; Lindblad LE
    Acta Med Scand; 1984; 215(4):333-9. PubMed ID: 6145298
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alpha- and beta-receptor blocking drugs in the treatment of hypertension.
    Ram CV; Kaplan NM
    Curr Probl Cardiol; 1979 Jan; 3(10):1-53. PubMed ID: 40755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.
    Koch G
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):725-8. PubMed ID: 10950
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Catecholamine-secreting neuroblastoma in a 4-month-old infant: perioperative management.
    Hernandez MR; Shamberger RC; Seefelder C
    J Clin Anesth; 2009 Feb; 21(1):54-6. PubMed ID: 19232942
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Guidelines on high blood pressure in pregnancy give new classifications of disease.
    Rollins G
    Rep Med Guidel Outcomes Res; 2000 Dec; 11(24):5-7. PubMed ID: 11902247
    [No Abstract]   [Full Text] [Related]  

  • 54. Combined alpha- and beta-blockade in the treatment of hypertension.
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):96-8. PubMed ID: 14629
    [No Abstract]   [Full Text] [Related]  

  • 55. Labetalol: a review of its pharmacology and therapeutic use in hypertension.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1978 Apr; 15(4):251-70. PubMed ID: 25757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Labetalol.
    Carter BL
    Drug Intell Clin Pharm; 1983 Oct; 17(10):704-12. PubMed ID: 6354658
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protective effects of simultaneous alpha and beta adrenergic receptor blockade on myocardial cell necrosis after coronary arterial occlusion in rats.
    Chiariello M; Brevetti G; DeRosa G; Acunzo R; Petillo F; Rengo F; Condorelli M
    Am J Cardiol; 1980 Aug; 46(2):249-54. PubMed ID: 6105820
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinico-experimental study of the new antihypertensive preparation abletol (labetalol)].
    Glezer GA; Smolenskiĭ VS; Porotikov VI; Meĭler SM; Khodzhamirova VS
    Kardiologiia; 1983 Aug; 23(8):12-6. PubMed ID: 6137588
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alternative mechanisms for the hypotensive effects of adrenergic blockade.
    Greer IA; Walker JJ; McLaren M; Belch JJ; Calder AA; Forbes CD
    Br Med J (Clin Res Ed); 1983 Nov; 287(6404):1551. PubMed ID: 6416498
    [No Abstract]   [Full Text] [Related]  

  • 60. [The new Russian preparation proxodolol in the treatment of arterial hypertension].
    Ol'binskaia LI; Morozova TE
    Eksp Klin Farmakol; 1994; 57(3):42-5. PubMed ID: 7914119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.